These findings demonstrate that the activity of KIRS2/Dap12-BB CAR is not antigen dependent, and mesothelin-targeted SS1-KIRS2/Dap12-BB CAR-T cells may have high translation potential anti-tumor activity against mesothelin-positive solid tumors. This evidence concerns the gene MSLN and neoplasm.